Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

iShares ESG Aware 60/40 Balanced Allocation ETF (NY:EAOR)

34.73 -0.06 (-0.17%)
Official Closing Price Updated: 8:00 PM EDT, Sep 12, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 100
Open 34.73
Bid (Size) 17.37 (1)
Ask (Size) 52.09 (1)
Prev. Close 34.79
Today's Range 34.73 - 34.73
52wk Range 28.94 - 34.79
Shares Outstanding N/A
Dividend Yield 2.97%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
RH Stock Sees Slew Of Downgrades, Price Target Cuts From Wall Street As Trump Tariffs Bite
Via Stocktwits
Topics Government
Soleno Therapeutics Stock Tanks After Patient Treated With Drug Dies – More Details Inside
Soleno said that its assessment of the death is the same as the treating physician, who said that the death is not related to the treatment with Vykat XR. 
Via Stocktwits
Topics Death

Performance

YTD
+10.9%
+10.9%
1 Month
+1.9%
+1.9%
3 Month
+6.6%
+6.6%
6 Month
+10.5%
+10.5%
1 Year
+9.6%
+9.6%

More News

Read More
Anavex Life Sciences Stock Rises After Experimental Alzheimer’s Drug Slows Cognitive Decline In Study
Via Stocktwits
This Aerospace Stock Witnessed A 700% Explosion In Retail Chatter On Stocktwits – More Details Inside
Via Stocktwits
IONS Stock Soars 34% To Hit February 2021 Highs After Medicine Shows Positive Effect On Elevated Triglyceride Levels In Late-Stage Studies
Via Stocktwits
Sarepta Just Got A Good Restructuring Deal For $700M Debt, But Stock Tumbles 7% – Here’s Why
Via Stocktwits
Soleno Therapeutics Stock Slumps After Scorpion Capital Reveals Short Position: But Retail’s Not Pessimistic Yet
Via Stocktwits
Inspire Medical Systems Stock Slumps On Downgrades, Price Target Cuts: Retail Believes Stock Is Way Oversold
Via Stocktwits
PTC Therapeutics Stock In The Spotlight After FDA Refuses Approval For Drug To Treat Neurodegenerative Disease, Analysts Are Divided
Via Stocktwits
CVS Health CFO Says Company Maintaining Prudent View On Medical Cost Trends Through Remainder Of Year
Via Stocktwits
Topics Artificial Intelligence Earnings Workforce
Why Did Sarepta Stock Jump 20% On Tuesday? Here’s What JPMorgan, Bernstein, Barclays Said About Elevidys
Via Stocktwits
Topics Death
Sarepta Draws Wall Street Ire After Third Patient Death This Year: Analyst Says ‘Deeply Concerning’ The Incident Wasn’t Reported Earlier
Via Stocktwits
Moderna’s Covid Vaccine Gets Full FDA Approval For Use In Children 6 Months And Older
Via Stocktwits
Organon Drops Drug Development For Endometriosis Pain After Mid-Stage Study Fails To Show Results
Via Stocktwits
Moderna Stock Surges Pre-Market As Flu Vaccine Shows Positive Results In Late-Stage Trial
Via Stocktwits

Frequently Asked Questions

Is iShares ESG Aware 60/40 Balanced Allocation ETF publicly traded?
Yes, iShares ESG Aware 60/40 Balanced Allocation ETF is publicly traded.
What exchange does iShares ESG Aware 60/40 Balanced Allocation ETF trade on?
iShares ESG Aware 60/40 Balanced Allocation ETF trades on the New York Stock Exchange
What is the ticker symbol for iShares ESG Aware 60/40 Balanced Allocation ETF?
The ticker symbol for iShares ESG Aware 60/40 Balanced Allocation ETF is EAOR on the New York Stock Exchange
What is the current price of iShares ESG Aware 60/40 Balanced Allocation ETF?
The current price of iShares ESG Aware 60/40 Balanced Allocation ETF is 34.73
When was iShares ESG Aware 60/40 Balanced Allocation ETF last traded?
The last trade of iShares ESG Aware 60/40 Balanced Allocation ETF was at 09/12/25 08:00 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.